MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.xkme.2025.101211

Медицинская библиотека · Kidney medicine · 2025

Multinational Real-World Practice Patterns in the Use of Antithrombotic Therapy Among Patients on Hemodialysis and Peritoneal Dialysis.

Guedes Murilo, Andrews Calvin, Zhao Junhui, Atkins G Brandon, Barash Irina, Bash Lori D, Coyle Catelyn R, Ke Xuehua, Ramey Dena R, Johnson David W, Ureña-Torres Pablo, Ferraro Pietro Manuel, Al Ghonaim Mohammed, Bonaca Marc P, Pecoits-Filho Roberto, Karaboyas Angelo

СтатьяПеревод в очереди

Аннотация

RATIONALE &

OBJECTIVE

Patients with kidney failure requiring maintenance dialysis have a high risk of cardiovascular events warranting antithrombotic therapies, including oral anticoagulant (OAC) or antiplatelet therapy (APT). However, chronic use of antithrombotic therapy can increase the bleeding risk in patients receiving dialysis. However, little is known about medication use patterns and risk of bleeding events in real-world clinical practice.

STUDY

DESIGN

Retrospective analysis of data from 2 prospective cohort studies.

SETTING &

PARTICIPANTS

We included 27,612 patients from the Dialysis Outcomes and Practice Patterns Study (DOPPS) and 5,289 patients from the Peritoneal DOPPS (PDOPPS), international cohorts of hemodialysis (HD) and peritoneal dialysis (PD) patients.

EXPOSURES: Patient demographics and comorbid conditions; OAC and APT use.

OUTCOMES: OAC and APT use; a bleeding composite outcome including a hospitalization or death because of a major bleeding event.

ANALYTICAL APPROACH: Descriptive analyses to explore OAC and APT utilization and crude rates of the bleeding composite outcome and Kaplan-Meier analyses to estimate medication discontinuation.

RESULTS

Baseline OAC and APT use was 9% and 10% in HD patients and 4% and 7% in PD patients, respectively. Patients prescribed antithrombotic drugs were older and more likely to have a history of cardiovascular disease. After 36 months, the Kaplan-Meier estimated proportions of baseline users who remained on therapy were 57% for OAC and 53% for APT. The composite bleeding rates per 100 patient-years among patients with baseline OAC use versus baseline APT use versus neither were 8.6, 5.6, and 4.1 in HD patients and 12.0, 6.1, and 3.9 in PD patients, respectively.

LIMITATIONS: Potential for event misclassification; no over-the-counter medication data; rates unadjusted.

CONCLUSIONS

Antithrombotic drugs are infrequently prescribed and often discontinued in patients receiving HD or PD. With major bleeding event rates high among antithrombotic users, new strategies are needed to optimize the risks and benefits of antithrombotic agents in the dialysis setting.

Для цитирования: Guedes Murilo, Andrews Calvin, Zhao Junhui, Atkins G Brandon, Barash Irina, Bash Lori D, Coyle Catelyn R, Ke Xuehua, Ramey Dena R, Johnson David W, Ureña-Torres Pablo, Ferraro Pietro Manuel, Al Ghonaim Mohammed, Bonaca Marc P, Pecoits-Filho Roberto, Karaboyas Angelo. Multinational Real-World Practice Patterns in the Use of Antithrombotic Therapy Among Patients on Hemodialysis and Peritoneal Dialysis.. Kidney medicine. 2025. DOI: 10.1016/j.xkme.2025.101211.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.